AGC Biologics’ $100M Infusion Revitalizes Dormant Boulder Facility
Manufacturing project positioned to accelerate Colorado bioscience employment and innovation
DENVER – The Colorado Office of Economic Development and International Trade (OEDIT) today announced that AGC Biologics has acquired an existing 300,000 square foot facility in Boulder which they will transform into a new manufacturing facility that will bring 280 new jobs to Colorado.